In this week’s podcast, Neurology Today’s editor-in-chief discusses the FDA approval of an antipsychotic for agitation in dementia, elevated risk for Parkinson’s in Camp Lejeune Marines exposed to contaminated water, a gene variant delays the onset of symptoms in man with autosomal dominant Alzheimer’s.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
In this week’s podcast, Neurology Today’s editor-in-chief discusses the FDA approval of an antipsychotic for agitation in dementia, elevated risk for Parkinson’s in Camp Lejeune Marines exposed to contaminated water, a gene variant delays the onset of symptoms in man with autosomal dominant Alzheimer’s.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
132 Listeners
7,683 Listeners
285 Listeners
322 Listeners
45 Listeners
496 Listeners
14 Listeners
186 Listeners
514 Listeners
132 Listeners
321 Listeners
182 Listeners
363 Listeners
2 Listeners
77 Listeners